Global Human Insulin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Human Insulin market size was valued at USD 57460 million in 2023 and is forecast to a readjusted size of USD 104760 million by 2030 with a CAGR of 9.0% during review period.
Human insulin is the name which describes synthetic insulin which is laboratory grown to mimic the insulin in humans.
In 2018, North America is estimated to dominate the global human insulin market. The Asia-Pacific market is poised to grow the fastest, during the forecast period, owing to growing diabetes prevalence in APAC (coupled with large diabetic & pre-diabetic patient population), strengthening distribution networks of global product manufacturers in the region, evolving regulatory framework for marketing approvals & medical reimbursements, continued expansion of advanced medical facilities in emerging countries (such as China & India), and rising public awareness related to benefits offered by human insulin in diabetes treatment.
The Global Info Research report includes an overview of the development of the Human Insulin industry chain, the market status of Short Acting (Insulin Analogs and Biosimilars, Human Insulin Biologics), Intermediate Acting (Insulin Analogs and Biosimilars, Human Insulin Biologics), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Human Insulin.
Regionally, the report analyzes the Human Insulin markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Human Insulin market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Human Insulin market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Human Insulin industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Doses), revenue generated, and market share of different by Type (e.g., Insulin Analogs and Biosimilars, Human Insulin Biologics).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Human Insulin market.
Regional Analysis: The report involves examining the Human Insulin market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Human Insulin market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Human Insulin:
Company Analysis: Report covers individual Human Insulin manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Human Insulin This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Short Acting, Intermediate Acting).
Technology Analysis: Report covers specific technologies relevant to Human Insulin. It assesses the current state, advancements, and potential future developments in Human Insulin areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Human Insulin market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Human Insulin market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Human Insulin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Insulin, with price, sales, revenue and global market share of Human Insulin from 2019 to 2024.
Chapter 3, the Human Insulin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Insulin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Human Insulin market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Insulin.
Chapter 14 and 15, to describe Human Insulin sales channel, distributors, customers, research findings and conclusion.
Human insulin is the name which describes synthetic insulin which is laboratory grown to mimic the insulin in humans.
In 2018, North America is estimated to dominate the global human insulin market. The Asia-Pacific market is poised to grow the fastest, during the forecast period, owing to growing diabetes prevalence in APAC (coupled with large diabetic & pre-diabetic patient population), strengthening distribution networks of global product manufacturers in the region, evolving regulatory framework for marketing approvals & medical reimbursements, continued expansion of advanced medical facilities in emerging countries (such as China & India), and rising public awareness related to benefits offered by human insulin in diabetes treatment.
The Global Info Research report includes an overview of the development of the Human Insulin industry chain, the market status of Short Acting (Insulin Analogs and Biosimilars, Human Insulin Biologics), Intermediate Acting (Insulin Analogs and Biosimilars, Human Insulin Biologics), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Human Insulin.
Regionally, the report analyzes the Human Insulin markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Human Insulin market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Human Insulin market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Human Insulin industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Doses), revenue generated, and market share of different by Type (e.g., Insulin Analogs and Biosimilars, Human Insulin Biologics).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Human Insulin market.
Regional Analysis: The report involves examining the Human Insulin market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Human Insulin market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Human Insulin:
Company Analysis: Report covers individual Human Insulin manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Human Insulin This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Short Acting, Intermediate Acting).
Technology Analysis: Report covers specific technologies relevant to Human Insulin. It assesses the current state, advancements, and potential future developments in Human Insulin areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Human Insulin market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Human Insulin market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Insulin Analogs and Biosimilars
- Human Insulin Biologics
- Short Acting
- Intermediate Acting
- Long Acting
- Pre-Mix Insulin
- B. Braun
- Becton, Dickinson
- Biocon
- Biodel
- ELI Lilly
- Julphar
- NOVO Nordisk
- Sanofi
- Wockhardt
- Ypsomed
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Human Insulin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Insulin, with price, sales, revenue and global market share of Human Insulin from 2019 to 2024.
Chapter 3, the Human Insulin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Insulin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Human Insulin market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Insulin.
Chapter 14 and 15, to describe Human Insulin sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Human Insulin
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Insulin Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Insulin Analogs and Biosimilars
1.3.3 Human Insulin Biologics
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Insulin Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Short Acting
1.4.3 Intermediate Acting
1.4.4 Long Acting
1.4.5 Pre-Mix Insulin
1.5 Global Human Insulin Market Size & Forecast
1.5.1 Global Human Insulin Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Human Insulin Sales Quantity (2019-2030)
1.5.3 Global Human Insulin Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 B. Braun
2.1.1 B. Braun Details
2.1.2 B. Braun Major Business
2.1.3 B. Braun Human Insulin Product and Services
2.1.4 B. Braun Human Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 B. Braun Recent Developments/Updates
2.2 Becton, Dickinson
2.2.1 Becton, Dickinson Details
2.2.2 Becton, Dickinson Major Business
2.2.3 Becton, Dickinson Human Insulin Product and Services
2.2.4 Becton, Dickinson Human Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Becton, Dickinson Recent Developments/Updates
2.3 Biocon
2.3.1 Biocon Details
2.3.2 Biocon Major Business
2.3.3 Biocon Human Insulin Product and Services
2.3.4 Biocon Human Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Biocon Recent Developments/Updates
2.4 Biodel
2.4.1 Biodel Details
2.4.2 Biodel Major Business
2.4.3 Biodel Human Insulin Product and Services
2.4.4 Biodel Human Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Biodel Recent Developments/Updates
2.5 ELI Lilly
2.5.1 ELI Lilly Details
2.5.2 ELI Lilly Major Business
2.5.3 ELI Lilly Human Insulin Product and Services
2.5.4 ELI Lilly Human Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 ELI Lilly Recent Developments/Updates
2.6 Julphar
2.6.1 Julphar Details
2.6.2 Julphar Major Business
2.6.3 Julphar Human Insulin Product and Services
2.6.4 Julphar Human Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Julphar Recent Developments/Updates
2.7 NOVO Nordisk
2.7.1 NOVO Nordisk Details
2.7.2 NOVO Nordisk Major Business
2.7.3 NOVO Nordisk Human Insulin Product and Services
2.7.4 NOVO Nordisk Human Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 NOVO Nordisk Recent Developments/Updates
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Human Insulin Product and Services
2.8.4 Sanofi Human Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Sanofi Recent Developments/Updates
2.9 Wockhardt
2.9.1 Wockhardt Details
2.9.2 Wockhardt Major Business
2.9.3 Wockhardt Human Insulin Product and Services
2.9.4 Wockhardt Human Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Wockhardt Recent Developments/Updates
2.10 Ypsomed
2.10.1 Ypsomed Details
2.10.2 Ypsomed Major Business
2.10.3 Ypsomed Human Insulin Product and Services
2.10.4 Ypsomed Human Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Ypsomed Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HUMAN INSULIN BY MANUFACTURER
3.1 Global Human Insulin Sales Quantity by Manufacturer (2019-2024)
3.2 Global Human Insulin Revenue by Manufacturer (2019-2024)
3.3 Global Human Insulin Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Human Insulin by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Human Insulin Manufacturer Market Share in 2023
3.4.2 Top 6 Human Insulin Manufacturer Market Share in 2023
3.5 Human Insulin Market: Overall Company Footprint Analysis
3.5.1 Human Insulin Market: Region Footprint
3.5.2 Human Insulin Market: Company Product Type Footprint
3.5.3 Human Insulin Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Human Insulin Market Size by Region
4.1.1 Global Human Insulin Sales Quantity by Region (2019-2030)
4.1.2 Global Human Insulin Consumption Value by Region (2019-2030)
4.1.3 Global Human Insulin Average Price by Region (2019-2030)
4.2 North America Human Insulin Consumption Value (2019-2030)
4.3 Europe Human Insulin Consumption Value (2019-2030)
4.4 Asia-Pacific Human Insulin Consumption Value (2019-2030)
4.5 South America Human Insulin Consumption Value (2019-2030)
4.6 Middle East and Africa Human Insulin Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Human Insulin Sales Quantity by Type (2019-2030)
5.2 Global Human Insulin Consumption Value by Type (2019-2030)
5.3 Global Human Insulin Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Human Insulin Sales Quantity by Application (2019-2030)
6.2 Global Human Insulin Consumption Value by Application (2019-2030)
6.3 Global Human Insulin Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Human Insulin Sales Quantity by Type (2019-2030)
7.2 North America Human Insulin Sales Quantity by Application (2019-2030)
7.3 North America Human Insulin Market Size by Country
7.3.1 North America Human Insulin Sales Quantity by Country (2019-2030)
7.3.2 North America Human Insulin Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Human Insulin Sales Quantity by Type (2019-2030)
8.2 Europe Human Insulin Sales Quantity by Application (2019-2030)
8.3 Europe Human Insulin Market Size by Country
8.3.1 Europe Human Insulin Sales Quantity by Country (2019-2030)
8.3.2 Europe Human Insulin Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Human Insulin Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Human Insulin Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Human Insulin Market Size by Region
9.3.1 Asia-Pacific Human Insulin Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Human Insulin Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Human Insulin Sales Quantity by Type (2019-2030)
10.2 South America Human Insulin Sales Quantity by Application (2019-2030)
10.3 South America Human Insulin Market Size by Country
10.3.1 South America Human Insulin Sales Quantity by Country (2019-2030)
10.3.2 South America Human Insulin Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Human Insulin Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Human Insulin Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Human Insulin Market Size by Country
11.3.1 Middle East & Africa Human Insulin Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Human Insulin Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Human Insulin Market Drivers
12.2 Human Insulin Market Restraints
12.3 Human Insulin Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Human Insulin and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Insulin
13.3 Human Insulin Production Process
13.4 Human Insulin Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Insulin Typical Distributors
14.3 Human Insulin Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Human Insulin
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Insulin Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Insulin Analogs and Biosimilars
1.3.3 Human Insulin Biologics
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Insulin Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Short Acting
1.4.3 Intermediate Acting
1.4.4 Long Acting
1.4.5 Pre-Mix Insulin
1.5 Global Human Insulin Market Size & Forecast
1.5.1 Global Human Insulin Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Human Insulin Sales Quantity (2019-2030)
1.5.3 Global Human Insulin Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 B. Braun
2.1.1 B. Braun Details
2.1.2 B. Braun Major Business
2.1.3 B. Braun Human Insulin Product and Services
2.1.4 B. Braun Human Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 B. Braun Recent Developments/Updates
2.2 Becton, Dickinson
2.2.1 Becton, Dickinson Details
2.2.2 Becton, Dickinson Major Business
2.2.3 Becton, Dickinson Human Insulin Product and Services
2.2.4 Becton, Dickinson Human Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Becton, Dickinson Recent Developments/Updates
2.3 Biocon
2.3.1 Biocon Details
2.3.2 Biocon Major Business
2.3.3 Biocon Human Insulin Product and Services
2.3.4 Biocon Human Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Biocon Recent Developments/Updates
2.4 Biodel
2.4.1 Biodel Details
2.4.2 Biodel Major Business
2.4.3 Biodel Human Insulin Product and Services
2.4.4 Biodel Human Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Biodel Recent Developments/Updates
2.5 ELI Lilly
2.5.1 ELI Lilly Details
2.5.2 ELI Lilly Major Business
2.5.3 ELI Lilly Human Insulin Product and Services
2.5.4 ELI Lilly Human Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 ELI Lilly Recent Developments/Updates
2.6 Julphar
2.6.1 Julphar Details
2.6.2 Julphar Major Business
2.6.3 Julphar Human Insulin Product and Services
2.6.4 Julphar Human Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Julphar Recent Developments/Updates
2.7 NOVO Nordisk
2.7.1 NOVO Nordisk Details
2.7.2 NOVO Nordisk Major Business
2.7.3 NOVO Nordisk Human Insulin Product and Services
2.7.4 NOVO Nordisk Human Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 NOVO Nordisk Recent Developments/Updates
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Human Insulin Product and Services
2.8.4 Sanofi Human Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Sanofi Recent Developments/Updates
2.9 Wockhardt
2.9.1 Wockhardt Details
2.9.2 Wockhardt Major Business
2.9.3 Wockhardt Human Insulin Product and Services
2.9.4 Wockhardt Human Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Wockhardt Recent Developments/Updates
2.10 Ypsomed
2.10.1 Ypsomed Details
2.10.2 Ypsomed Major Business
2.10.3 Ypsomed Human Insulin Product and Services
2.10.4 Ypsomed Human Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Ypsomed Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HUMAN INSULIN BY MANUFACTURER
3.1 Global Human Insulin Sales Quantity by Manufacturer (2019-2024)
3.2 Global Human Insulin Revenue by Manufacturer (2019-2024)
3.3 Global Human Insulin Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Human Insulin by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Human Insulin Manufacturer Market Share in 2023
3.4.2 Top 6 Human Insulin Manufacturer Market Share in 2023
3.5 Human Insulin Market: Overall Company Footprint Analysis
3.5.1 Human Insulin Market: Region Footprint
3.5.2 Human Insulin Market: Company Product Type Footprint
3.5.3 Human Insulin Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Human Insulin Market Size by Region
4.1.1 Global Human Insulin Sales Quantity by Region (2019-2030)
4.1.2 Global Human Insulin Consumption Value by Region (2019-2030)
4.1.3 Global Human Insulin Average Price by Region (2019-2030)
4.2 North America Human Insulin Consumption Value (2019-2030)
4.3 Europe Human Insulin Consumption Value (2019-2030)
4.4 Asia-Pacific Human Insulin Consumption Value (2019-2030)
4.5 South America Human Insulin Consumption Value (2019-2030)
4.6 Middle East and Africa Human Insulin Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Human Insulin Sales Quantity by Type (2019-2030)
5.2 Global Human Insulin Consumption Value by Type (2019-2030)
5.3 Global Human Insulin Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Human Insulin Sales Quantity by Application (2019-2030)
6.2 Global Human Insulin Consumption Value by Application (2019-2030)
6.3 Global Human Insulin Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Human Insulin Sales Quantity by Type (2019-2030)
7.2 North America Human Insulin Sales Quantity by Application (2019-2030)
7.3 North America Human Insulin Market Size by Country
7.3.1 North America Human Insulin Sales Quantity by Country (2019-2030)
7.3.2 North America Human Insulin Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Human Insulin Sales Quantity by Type (2019-2030)
8.2 Europe Human Insulin Sales Quantity by Application (2019-2030)
8.3 Europe Human Insulin Market Size by Country
8.3.1 Europe Human Insulin Sales Quantity by Country (2019-2030)
8.3.2 Europe Human Insulin Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Human Insulin Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Human Insulin Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Human Insulin Market Size by Region
9.3.1 Asia-Pacific Human Insulin Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Human Insulin Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Human Insulin Sales Quantity by Type (2019-2030)
10.2 South America Human Insulin Sales Quantity by Application (2019-2030)
10.3 South America Human Insulin Market Size by Country
10.3.1 South America Human Insulin Sales Quantity by Country (2019-2030)
10.3.2 South America Human Insulin Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Human Insulin Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Human Insulin Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Human Insulin Market Size by Country
11.3.1 Middle East & Africa Human Insulin Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Human Insulin Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Human Insulin Market Drivers
12.2 Human Insulin Market Restraints
12.3 Human Insulin Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Human Insulin and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Insulin
13.3 Human Insulin Production Process
13.4 Human Insulin Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Insulin Typical Distributors
14.3 Human Insulin Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Human Insulin Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Human Insulin Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. B. Braun Basic Information, Manufacturing Base and Competitors
Table 4. B. Braun Major Business
Table 5. B. Braun Human Insulin Product and Services
Table 6. B. Braun Human Insulin Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. B. Braun Recent Developments/Updates
Table 8. Becton, Dickinson Basic Information, Manufacturing Base and Competitors
Table 9. Becton, Dickinson Major Business
Table 10. Becton, Dickinson Human Insulin Product and Services
Table 11. Becton, Dickinson Human Insulin Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Becton, Dickinson Recent Developments/Updates
Table 13. Biocon Basic Information, Manufacturing Base and Competitors
Table 14. Biocon Major Business
Table 15. Biocon Human Insulin Product and Services
Table 16. Biocon Human Insulin Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Biocon Recent Developments/Updates
Table 18. Biodel Basic Information, Manufacturing Base and Competitors
Table 19. Biodel Major Business
Table 20. Biodel Human Insulin Product and Services
Table 21. Biodel Human Insulin Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Biodel Recent Developments/Updates
Table 23. ELI Lilly Basic Information, Manufacturing Base and Competitors
Table 24. ELI Lilly Major Business
Table 25. ELI Lilly Human Insulin Product and Services
Table 26. ELI Lilly Human Insulin Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. ELI Lilly Recent Developments/Updates
Table 28. Julphar Basic Information, Manufacturing Base and Competitors
Table 29. Julphar Major Business
Table 30. Julphar Human Insulin Product and Services
Table 31. Julphar Human Insulin Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Julphar Recent Developments/Updates
Table 33. NOVO Nordisk Basic Information, Manufacturing Base and Competitors
Table 34. NOVO Nordisk Major Business
Table 35. NOVO Nordisk Human Insulin Product and Services
Table 36. NOVO Nordisk Human Insulin Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. NOVO Nordisk Recent Developments/Updates
Table 38. Sanofi Basic Information, Manufacturing Base and Competitors
Table 39. Sanofi Major Business
Table 40. Sanofi Human Insulin Product and Services
Table 41. Sanofi Human Insulin Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Sanofi Recent Developments/Updates
Table 43. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 44. Wockhardt Major Business
Table 45. Wockhardt Human Insulin Product and Services
Table 46. Wockhardt Human Insulin Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Wockhardt Recent Developments/Updates
Table 48. Ypsomed Basic Information, Manufacturing Base and Competitors
Table 49. Ypsomed Major Business
Table 50. Ypsomed Human Insulin Product and Services
Table 51. Ypsomed Human Insulin Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Ypsomed Recent Developments/Updates
Table 53. Global Human Insulin Sales Quantity by Manufacturer (2019-2024) & (K Doses)
Table 54. Global Human Insulin Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Human Insulin Average Price by Manufacturer (2019-2024) & (USD/Dose)
Table 56. Market Position of Manufacturers in Human Insulin, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Human Insulin Production Site of Key Manufacturer
Table 58. Human Insulin Market: Company Product Type Footprint
Table 59. Human Insulin Market: Company Product Application Footprint
Table 60. Human Insulin New Market Entrants and Barriers to Market Entry
Table 61. Human Insulin Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Human Insulin Sales Quantity by Region (2019-2024) & (K Doses)
Table 63. Global Human Insulin Sales Quantity by Region (2025-2030) & (K Doses)
Table 64. Global Human Insulin Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Human Insulin Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Human Insulin Average Price by Region (2019-2024) & (USD/Dose)
Table 67. Global Human Insulin Average Price by Region (2025-2030) & (USD/Dose)
Table 68. Global Human Insulin Sales Quantity by Type (2019-2024) & (K Doses)
Table 69. Global Human Insulin Sales Quantity by Type (2025-2030) & (K Doses)
Table 70. Global Human Insulin Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Human Insulin Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Human Insulin Average Price by Type (2019-2024) & (USD/Dose)
Table 73. Global Human Insulin Average Price by Type (2025-2030) & (USD/Dose)
Table 74. Global Human Insulin Sales Quantity by Application (2019-2024) & (K Doses)
Table 75. Global Human Insulin Sales Quantity by Application (2025-2030) & (K Doses)
Table 76. Global Human Insulin Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Human Insulin Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Human Insulin Average Price by Application (2019-2024) & (USD/Dose)
Table 79. Global Human Insulin Average Price by Application (2025-2030) & (USD/Dose)
Table 80. North America Human Insulin Sales Quantity by Type (2019-2024) & (K Doses)
Table 81. North America Human Insulin Sales Quantity by Type (2025-2030) & (K Doses)
Table 82. North America Human Insulin Sales Quantity by Application (2019-2024) & (K Doses)
Table 83. North America Human Insulin Sales Quantity by Application (2025-2030) & (K Doses)
Table 84. North America Human Insulin Sales Quantity by Country (2019-2024) & (K Doses)
Table 85. North America Human Insulin Sales Quantity by Country (2025-2030) & (K Doses)
Table 86. North America Human Insulin Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Human Insulin Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Human Insulin Sales Quantity by Type (2019-2024) & (K Doses)
Table 89. Europe Human Insulin Sales Quantity by Type (2025-2030) & (K Doses)
Table 90. Europe Human Insulin Sales Quantity by Application (2019-2024) & (K Doses)
Table 91. Europe Human Insulin Sales Quantity by Application (2025-2030) & (K Doses)
Table 92. Europe Human Insulin Sales Quantity by Country (2019-2024) & (K Doses)
Table 93. Europe Human Insulin Sales Quantity by Country (2025-2030) & (K Doses)
Table 94. Europe Human Insulin Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Human Insulin Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Human Insulin Sales Quantity by Type (2019-2024) & (K Doses)
Table 97. Asia-Pacific Human Insulin Sales Quantity by Type (2025-2030) & (K Doses)
Table 98. Asia-Pacific Human Insulin Sales Quantity by Application (2019-2024) & (K Doses)
Table 99. Asia-Pacific Human Insulin Sales Quantity by Application (2025-2030) & (K Doses)
Table 100. Asia-Pacific Human Insulin Sales Quantity by Region (2019-2024) & (K Doses)
Table 101. Asia-Pacific Human Insulin Sales Quantity by Region (2025-2030) & (K Doses)
Table 102. Asia-Pacific Human Insulin Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Human Insulin Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Human Insulin Sales Quantity by Type (2019-2024) & (K Doses)
Table 105. South America Human Insulin Sales Quantity by Type (2025-2030) & (K Doses)
Table 106. South America Human Insulin Sales Quantity by Application (2019-2024) & (K Doses)
Table 107. South America Human Insulin Sales Quantity by Application (2025-2030) & (K Doses)
Table 108. South America Human Insulin Sales Quantity by Country (2019-2024) & (K Doses)
Table 109. South America Human Insulin Sales Quantity by Country (2025-2030) & (K Doses)
Table 110. South America Human Insulin Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Human Insulin Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Human Insulin Sales Quantity by Type (2019-2024) & (K Doses)
Table 113. Middle East & Africa Human Insulin Sales Quantity by Type (2025-2030) & (K Doses)
Table 114. Middle East & Africa Human Insulin Sales Quantity by Application (2019-2024) & (K Doses)
Table 115. Middle East & Africa Human Insulin Sales Quantity by Application (2025-2030) & (K Doses)
Table 116. Middle East & Africa Human Insulin Sales Quantity by Region (2019-2024) & (K Doses)
Table 117. Middle East & Africa Human Insulin Sales Quantity by Region (2025-2030) & (K Doses)
Table 118. Middle East & Africa Human Insulin Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Human Insulin Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Human Insulin Raw Material
Table 121. Key Manufacturers of Human Insulin Raw Materials
Table 122. Human Insulin Typical Distributors
Table 123. Human Insulin Typical Customers
Table 1. Global Human Insulin Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Human Insulin Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. B. Braun Basic Information, Manufacturing Base and Competitors
Table 4. B. Braun Major Business
Table 5. B. Braun Human Insulin Product and Services
Table 6. B. Braun Human Insulin Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. B. Braun Recent Developments/Updates
Table 8. Becton, Dickinson Basic Information, Manufacturing Base and Competitors
Table 9. Becton, Dickinson Major Business
Table 10. Becton, Dickinson Human Insulin Product and Services
Table 11. Becton, Dickinson Human Insulin Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Becton, Dickinson Recent Developments/Updates
Table 13. Biocon Basic Information, Manufacturing Base and Competitors
Table 14. Biocon Major Business
Table 15. Biocon Human Insulin Product and Services
Table 16. Biocon Human Insulin Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Biocon Recent Developments/Updates
Table 18. Biodel Basic Information, Manufacturing Base and Competitors
Table 19. Biodel Major Business
Table 20. Biodel Human Insulin Product and Services
Table 21. Biodel Human Insulin Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Biodel Recent Developments/Updates
Table 23. ELI Lilly Basic Information, Manufacturing Base and Competitors
Table 24. ELI Lilly Major Business
Table 25. ELI Lilly Human Insulin Product and Services
Table 26. ELI Lilly Human Insulin Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. ELI Lilly Recent Developments/Updates
Table 28. Julphar Basic Information, Manufacturing Base and Competitors
Table 29. Julphar Major Business
Table 30. Julphar Human Insulin Product and Services
Table 31. Julphar Human Insulin Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Julphar Recent Developments/Updates
Table 33. NOVO Nordisk Basic Information, Manufacturing Base and Competitors
Table 34. NOVO Nordisk Major Business
Table 35. NOVO Nordisk Human Insulin Product and Services
Table 36. NOVO Nordisk Human Insulin Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. NOVO Nordisk Recent Developments/Updates
Table 38. Sanofi Basic Information, Manufacturing Base and Competitors
Table 39. Sanofi Major Business
Table 40. Sanofi Human Insulin Product and Services
Table 41. Sanofi Human Insulin Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Sanofi Recent Developments/Updates
Table 43. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 44. Wockhardt Major Business
Table 45. Wockhardt Human Insulin Product and Services
Table 46. Wockhardt Human Insulin Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Wockhardt Recent Developments/Updates
Table 48. Ypsomed Basic Information, Manufacturing Base and Competitors
Table 49. Ypsomed Major Business
Table 50. Ypsomed Human Insulin Product and Services
Table 51. Ypsomed Human Insulin Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Ypsomed Recent Developments/Updates
Table 53. Global Human Insulin Sales Quantity by Manufacturer (2019-2024) & (K Doses)
Table 54. Global Human Insulin Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Human Insulin Average Price by Manufacturer (2019-2024) & (USD/Dose)
Table 56. Market Position of Manufacturers in Human Insulin, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Human Insulin Production Site of Key Manufacturer
Table 58. Human Insulin Market: Company Product Type Footprint
Table 59. Human Insulin Market: Company Product Application Footprint
Table 60. Human Insulin New Market Entrants and Barriers to Market Entry
Table 61. Human Insulin Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Human Insulin Sales Quantity by Region (2019-2024) & (K Doses)
Table 63. Global Human Insulin Sales Quantity by Region (2025-2030) & (K Doses)
Table 64. Global Human Insulin Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Human Insulin Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Human Insulin Average Price by Region (2019-2024) & (USD/Dose)
Table 67. Global Human Insulin Average Price by Region (2025-2030) & (USD/Dose)
Table 68. Global Human Insulin Sales Quantity by Type (2019-2024) & (K Doses)
Table 69. Global Human Insulin Sales Quantity by Type (2025-2030) & (K Doses)
Table 70. Global Human Insulin Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Human Insulin Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Human Insulin Average Price by Type (2019-2024) & (USD/Dose)
Table 73. Global Human Insulin Average Price by Type (2025-2030) & (USD/Dose)
Table 74. Global Human Insulin Sales Quantity by Application (2019-2024) & (K Doses)
Table 75. Global Human Insulin Sales Quantity by Application (2025-2030) & (K Doses)
Table 76. Global Human Insulin Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Human Insulin Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Human Insulin Average Price by Application (2019-2024) & (USD/Dose)
Table 79. Global Human Insulin Average Price by Application (2025-2030) & (USD/Dose)
Table 80. North America Human Insulin Sales Quantity by Type (2019-2024) & (K Doses)
Table 81. North America Human Insulin Sales Quantity by Type (2025-2030) & (K Doses)
Table 82. North America Human Insulin Sales Quantity by Application (2019-2024) & (K Doses)
Table 83. North America Human Insulin Sales Quantity by Application (2025-2030) & (K Doses)
Table 84. North America Human Insulin Sales Quantity by Country (2019-2024) & (K Doses)
Table 85. North America Human Insulin Sales Quantity by Country (2025-2030) & (K Doses)
Table 86. North America Human Insulin Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Human Insulin Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Human Insulin Sales Quantity by Type (2019-2024) & (K Doses)
Table 89. Europe Human Insulin Sales Quantity by Type (2025-2030) & (K Doses)
Table 90. Europe Human Insulin Sales Quantity by Application (2019-2024) & (K Doses)
Table 91. Europe Human Insulin Sales Quantity by Application (2025-2030) & (K Doses)
Table 92. Europe Human Insulin Sales Quantity by Country (2019-2024) & (K Doses)
Table 93. Europe Human Insulin Sales Quantity by Country (2025-2030) & (K Doses)
Table 94. Europe Human Insulin Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Human Insulin Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Human Insulin Sales Quantity by Type (2019-2024) & (K Doses)
Table 97. Asia-Pacific Human Insulin Sales Quantity by Type (2025-2030) & (K Doses)
Table 98. Asia-Pacific Human Insulin Sales Quantity by Application (2019-2024) & (K Doses)
Table 99. Asia-Pacific Human Insulin Sales Quantity by Application (2025-2030) & (K Doses)
Table 100. Asia-Pacific Human Insulin Sales Quantity by Region (2019-2024) & (K Doses)
Table 101. Asia-Pacific Human Insulin Sales Quantity by Region (2025-2030) & (K Doses)
Table 102. Asia-Pacific Human Insulin Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Human Insulin Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Human Insulin Sales Quantity by Type (2019-2024) & (K Doses)
Table 105. South America Human Insulin Sales Quantity by Type (2025-2030) & (K Doses)
Table 106. South America Human Insulin Sales Quantity by Application (2019-2024) & (K Doses)
Table 107. South America Human Insulin Sales Quantity by Application (2025-2030) & (K Doses)
Table 108. South America Human Insulin Sales Quantity by Country (2019-2024) & (K Doses)
Table 109. South America Human Insulin Sales Quantity by Country (2025-2030) & (K Doses)
Table 110. South America Human Insulin Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Human Insulin Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Human Insulin Sales Quantity by Type (2019-2024) & (K Doses)
Table 113. Middle East & Africa Human Insulin Sales Quantity by Type (2025-2030) & (K Doses)
Table 114. Middle East & Africa Human Insulin Sales Quantity by Application (2019-2024) & (K Doses)
Table 115. Middle East & Africa Human Insulin Sales Quantity by Application (2025-2030) & (K Doses)
Table 116. Middle East & Africa Human Insulin Sales Quantity by Region (2019-2024) & (K Doses)
Table 117. Middle East & Africa Human Insulin Sales Quantity by Region (2025-2030) & (K Doses)
Table 118. Middle East & Africa Human Insulin Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Human Insulin Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Human Insulin Raw Material
Table 121. Key Manufacturers of Human Insulin Raw Materials
Table 122. Human Insulin Typical Distributors
Table 123. Human Insulin Typical Customers
LIST OF FIGURES
Figure 1. Human Insulin Picture
Figure 2. Global Human Insulin Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Human Insulin Consumption Value Market Share by Type in 2023
Figure 4. Insulin Analogs and Biosimilars Examples
Figure 5. Human Insulin Biologics Examples
Figure 6. Global Human Insulin Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Human Insulin Consumption Value Market Share by Application in 2023
Figure 8. Short Acting Examples
Figure 9. Intermediate Acting Examples
Figure 10. Long Acting Examples
Figure 11. Pre-Mix Insulin Examples
Figure 12. Global Human Insulin Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Human Insulin Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Human Insulin Sales Quantity (2019-2030) & (K Doses)
Figure 15. Global Human Insulin Average Price (2019-2030) & (USD/Dose)
Figure 16. Global Human Insulin Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Human Insulin Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Human Insulin by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Human Insulin Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Human Insulin Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Human Insulin Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Human Insulin Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Human Insulin Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Human Insulin Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Human Insulin Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Human Insulin Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Human Insulin Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Human Insulin Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Human Insulin Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Human Insulin Average Price by Type (2019-2030) & (USD/Dose)
Figure 31. Global Human Insulin Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Human Insulin Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Human Insulin Average Price by Application (2019-2030) & (USD/Dose)
Figure 34. North America Human Insulin Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Human Insulin Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Human Insulin Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Human Insulin Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Human Insulin Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Human Insulin Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Human Insulin Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Human Insulin Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Human Insulin Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Human Insulin Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Human Insulin Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Human Insulin Consumption Value Market Share by Region (2019-2030)
Figure 54. China Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Human Insulin Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Human Insulin Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Human Insulin Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Human Insulin Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Human Insulin Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Human Insulin Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Human Insulin Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Human Insulin Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Human Insulin Market Drivers
Figure 75. Human Insulin Market Restraints
Figure 76. Human Insulin Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Human Insulin in 2023
Figure 79. Manufacturing Process Analysis of Human Insulin
Figure 80. Human Insulin Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Human Insulin Picture
Figure 2. Global Human Insulin Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Human Insulin Consumption Value Market Share by Type in 2023
Figure 4. Insulin Analogs and Biosimilars Examples
Figure 5. Human Insulin Biologics Examples
Figure 6. Global Human Insulin Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Human Insulin Consumption Value Market Share by Application in 2023
Figure 8. Short Acting Examples
Figure 9. Intermediate Acting Examples
Figure 10. Long Acting Examples
Figure 11. Pre-Mix Insulin Examples
Figure 12. Global Human Insulin Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Human Insulin Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Human Insulin Sales Quantity (2019-2030) & (K Doses)
Figure 15. Global Human Insulin Average Price (2019-2030) & (USD/Dose)
Figure 16. Global Human Insulin Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Human Insulin Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Human Insulin by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Human Insulin Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Human Insulin Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Human Insulin Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Human Insulin Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Human Insulin Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Human Insulin Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Human Insulin Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Human Insulin Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Human Insulin Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Human Insulin Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Human Insulin Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Human Insulin Average Price by Type (2019-2030) & (USD/Dose)
Figure 31. Global Human Insulin Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Human Insulin Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Human Insulin Average Price by Application (2019-2030) & (USD/Dose)
Figure 34. North America Human Insulin Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Human Insulin Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Human Insulin Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Human Insulin Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Human Insulin Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Human Insulin Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Human Insulin Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Human Insulin Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Human Insulin Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Human Insulin Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Human Insulin Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Human Insulin Consumption Value Market Share by Region (2019-2030)
Figure 54. China Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Human Insulin Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Human Insulin Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Human Insulin Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Human Insulin Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Human Insulin Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Human Insulin Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Human Insulin Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Human Insulin Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Human Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Human Insulin Market Drivers
Figure 75. Human Insulin Market Restraints
Figure 76. Human Insulin Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Human Insulin in 2023
Figure 79. Manufacturing Process Analysis of Human Insulin
Figure 80. Human Insulin Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
